Original Article

You have full text access to this OnlineOpen article

Osthole stimulates osteoblast differentiation and bone formation by activation of β-catenin–BMP signaling

  1. De-Zhi Tang1,2,
  2. Wei Hou1,2,
  3. Quan Zhou1,
  4. Minjie Zhang2,
  5. Jonathan Holz2,
  6. Tzong-Jen Sheu2,
  7. Tian-Fang Li2,
  8. Shao-Dan Cheng1,
  9. Qi Shi1,3,
  10. Stephen E Harris4,
  11. Di Chen2,*,
  12. Yong-Jun Wang1,3,*

Article first published online: 15 JAN 2010

DOI: 10.1002/jbmr.21

Issue

Journal of Bone and Mineral Research

Journal of Bone and Mineral Research

Volume 25, Issue 6, pages 1234–1245, June 2010

Additional Information

How to Cite

Tang, D.-Z., Hou, W., Zhou, Q., Zhang, M., Holz, J., Sheu, T.-J., Li, T.-F., Cheng, S.-D., Shi, Q., Harris, S. E., Chen, D. and Wang, Y.-J. (2010), Osthole stimulates osteoblast differentiation and bone formation by activation of β-catenin–BMP signaling. J Bone Miner Res, 25: 1234–1245. doi: 10.1002/jbmr.21

Author Information

  1. 1

    Spine Research Institute, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China

  2. 2

    Department of Orthopaedics, Center for Musculoskeletal Research, University of Rochester, Rochester, NY, USA

  3. 3

    Department of Orthopaedics & Traumatology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China

  4. 4

    Department of Periodontics, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA

*Department of Orthopaedics, Center for Musculoskeletal Research, University of Rochester School of Medicine, Rochester, NY 14642, USA.

Publication History

  1. Issue published online: 27 MAY 2010
  2. Article first published online: 15 JAN 2010
  3. Accepted manuscript online: 15 JAN 2010 12:00AM EST
  4. Manuscript Accepted: 29 DEC 2009
  5. Manuscript Revised: 6 NOV 2009
  6. Manuscript Received: 12 MAY 2009

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (431K)

References

  • 1
    Messinger-Rapport BJ, Thacker HL. Prevention for the older woman. A practical guide to prevention and treatment of osteoporosis. Geriatrics. 2002; 57: 16-8, 21-4, 27.
  • 2
    Mulligan R, Sobel S. Osteoporosis: diagnostic testing, interpretation, and correlations with oral health: implications for dentistry. Dent Clin North Am. 2005; 49: 463–84.
  • 3
    Riggs BL, Melton LJ 3rd. The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone. 1995; 17: 505S–511S.
  • 4
    Pluijm SM, Koes B, de Laet C, et al. A simple risk score for the assessment of absolute fracture risk in general practice based on two longitudinal studies. J Bone Miner Res. 2009; 24: 768–74.
    Direct Link:
  • 5
    Cauley JA, Lui LY, Genant HK, et al. Study of Osteoporotic Fractures Research and Group Risk factors for severity and type of the hip fracture. J Bone Miner Res. 2009; 24: 943–55.
    Direct Link:
  • 6
    Rubin CD. Emerging concepts in osteoporosis and bone strength. Curr Med Res Opin. 2005; 21: 1049–56.
  • 7
    Khosla S, Burr D, Cauley J, et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2007; 22: 1479–91.
    Direct Link:
  • 8
    Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg. 2007; 65: 369–76.
  • 9
    Bilezikian JP. Combination anabolic and antiresorptive therapy for osteoporosis: opening the anabolic window. Curr Osteoporos Rep. 2008; 6: 24–30.
  • 10
    Chesnut CH 3rd, Rosen CJ. Reconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture. J Bone Miner Res. 2001; 16: 2163–72.
    Direct Link:
  • 11
    Black DM, Greenspan SL, Ensrud KE, et al. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med. 2003; 349: 1207–15.
  • 12
    Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med. 2003; 349: 1216–26.
  • 13
    Styrkarsdottir U, Cazier JB, Kong A, et al. Linkage of osteoporosis to chromosome 20p12 and association to BMP2. PLoS Biol. 2003; 1: E69.
  • 14
    Ramesh Babu L, Wilson SG, Dick IM, Islam FM, Devine A, Prince RL. Bone mass effects of a BMP4 gene polymorphism in postmenopausal women. Bone. 2005; 36: 555–61.
  • 15
    Mundy G, Garrett R, Harris S, et al. Stimulation of bone formation in vitro and in rodents by statins. Science. 1999; 286: 1946–9.
  • 16
    Garrett IR, Chen D, Gutierrez G, et al. Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro. J Clin Invest. 2003; 111: 1771–82.
  • 17
    Zhao M, Ko SY, Liu JH, et al. Inhibition of microtubule assembly in osteoblasts stimulates bone morphogenetic protein 2 expression and bone formation through transcription factor Gli2. Mol Cell Biol. 2009; 29: 1291–305.
  • 18
    Zhao M, Qiao M, Harris SE, Chen D, Oyajobi BO, Mundy GR. The zinc finger transcription factor Gli2 mediates bone morphogenetic protein 2 expression in osteoblasts in response to hedgehog signaling. Mol Cell Biol. 2006; 26: 6197–208.
  • 19
    Bilican B, Fiore-Heriche C, Compston A, Allen ND, Chandran S. Induction of Olig2 precursors by FGF involves BMP signalling blockade at the Smad level. PLoS ONE. 2008; 3: e2863.
  • 20
    Cao X, Chen D. The BMP signaling and in vivo bone formation. Gene. 2005; 357: 1–8.
  • 21
    Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors. 2004; 22: 233–41.
  • 22
    Miyazono K, Maeda S, Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 2005; 16: 251–63.
  • 23
    Wan M, Cao X. BMP signaling in skeletal development. Biochem Biophys Res Commun. 2005; 328: 651–7.
  • 24
    Tang Y, Tang W, Lin Y, et al. Combination of bone tissue engineering and BMP2 gene transfection promotes bone healing in osteoporotic rats. Cell Biol Int. 2008; 32: 1150–7.
  • 25
    Zhao M, Harris SE, Horn D, et al. Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation. J Cell Biol. 2002; 157: 1049–60.
  • 26
    Zhao M, Qiao M, Harris SE, Oyajobi BO, Mundy GR, Chen D. Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivo. J Biol Chem. 2004; 279: 12854–9.
  • 27
    Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987; 2: 595–610.
    Direct Link:
  • 28
    Yan Y, Tang D, Chen M, et al. Axin2 controls bone remodeling through the β-catenin-BMP signaling pathway in adult mice. J Cell Sci. 2009; 122: 3566–3578.
  • 29
    Zhao M, Qiao M, Oyajobi BO, Mundy GR, Chen D. E3 ubiquitin ligase Smurf1 mediates core-binding factor α1/Runx2 degradation and plays a specific role in osteoblast differentiation. J Biol Chem. 2003; 278: 27939–44.
  • 30
    Chen M, Zhu M, Awad H, et al. Inhibition of β-catenin signaling causes defects in postnatal cartilage development. J Cell Sci. 2008; 121: 1455–65.
  • 31
    Zhu M, Tang D, Wu Q, et al. Activation of beta-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult β-catenin conditional activation mice. J Bone Miner Res. 2009; 24: 12–21.
    Direct Link:
  • 32
    Ko FN, Wu TS, Liou MJ, Huang TF, Teng CM. Vasorelaxation of rat thoracic aorta caused by osthole isolated from Angelica pubescens. Eur J Pharmacol. 1992; 219: 29–34.
  • 33
    Teng CM, Lin CH, Ko FN, Wu TS, Huang TF. The relaxant action of osthole isolated from Angelica pubescens in guinea-pig trachea. Naunyn Schmiedebergs Arch Pharmacol. 1994; 349: 202–8.
  • 34
    Li XX, Hara I, Matsumiya T. Effects of osthole on postmenopausal osteoporosis using ovariectomized rats; comparison to the effects of estradiol. Biol Pharm Bull. 2002; 25: 738–42.
  • 35
    Tang Y, Tang W, Lin Y, et al. Combination of bone tissue engineering and BMP2 gene transfection promotes bone healing in osteoporotic rats. Cell Biol Int. 2008; 32: 1150–7.
  • 36
    Meng F, Xiong Z, Sun Y, Li F. Coumarins from Cnidium monnieri (L.) and their proliferation stimulating activity on osteoblast-like UMR106 cells. Pharmazie. 2004; 59: 643–5.
  • 37
    Kuo PL, Hsu YL, Chang CH, Chang JK. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells. J Pharmacol Exp Ther. 2005; 314: 1290–9.
View Full Article (HTML) Get PDF (431K)